Immuno-Biological Laboratories (4570)
Company Profile
(As of March 2009)
| Company Name | Immuno-Biological Laboratories Co., Ltd. | Head Office | 5-1 Aramachi Takasaki-shi Gunma 370-0831 | |
| Phone | 81-27-310-8040 | Listed on | Hercules | |
| Established | September 9, 1982 | Exchange Listing | March 2, 2007 | |
| Homepage | http://www.ibl-japan.co.jp/eng/index.htm | IR Web | http://www.ibl-japan.co.jp/eng/ir.htm | |
| IR Contact | IR Phone | |||
| IR Mail | do-investor-relations@ibl-japan.co.jp | |||
| Consolidated Segment Data (Sales, OP) | Reagents related business for R&D(54.36%、%) | Top Shareholders | Tsutomu Seito | 18.08% |
| Laboratory animal related business (34.69%, -%) | Iwai Chemicals Co. | 3.24% | ||
| Drug discovery related business (10.58%, -%) | Nomura Research & Advisory | 2.99% | ||
| Other(0.38%, -%) | Nobuyuki Matsumura | 2.69% | ||
| Directors | Tsutomu Seito, President | Nikko Ant Factory Co., Ltd. | 2.43% | |
| Masahiro Maeda, Director | Nichirei Bio Science | 2.43% | ||
| Masato Nakagawa, Director | Eiken Chemical Co., Ltd. | 2.02% | ||
| Masanari Kawaminami, Director | Kiyoshi Umemura | 1.97% | ||
| Kiyoshi Imaizumi, Standing Auditor | C-Investment | 1.94% | ||
| Yasuyoshi Ishihara, Auditor | Jafco Co., Ltd. | 1.81% | ||
| Hiroyuki Watanabe, Auditor | Shares Outstanding | 616 thousand shares | (As of March 2009) | |
| 7 others | Shareholders Capital | 1,572 million yen | (As of March 2009) | |
| (As of March 2009) | Subsidiaries | |||
| Employees (Cons) | n.a. | Main Banks | The Gunma Bank, Ltd., Mizuho Bank, Ltd., The Towa Bank, Ltd. | |
| Employees (Par) | 68 | Credit Ratings | n.a. | |
| Average Age (Par) | 39 | Auditors | Ernst & Young ShinNihon LLC | |
| Annual Salary (Par) | ||||

